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Abstract
Background: This study compares the frequency and distribution of increased activity on 18 F-fluoride PET/CT with
the presence of bone marrow edema on whole-body MR imaging in the spine and sacroiliac joints (SIJ) of patients
with active ankylosing spondylitis (AS).
Methods: Ten patients (6 men and 4 women), between 30 and 58 years old (median 44) with active AS, were
prospectively examined with both whole-body MRI and 18 F-fluoride PET/CT. Patients fulfilled modified NY criteria
and had a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of at least 4. Increased radiotracer uptake in
PET/CT and bone marrow edema in whole-body MRI of spine and SIJ was evaluated independently by two blinded
observers for each modality. Kappa statistics were used to compare interobserver agreement as well as scores of
consensus reading of the two imaging modalities.
Results: Analysis of interobserver agreement for PET/CT yielded a kappa value of 0.68 for spinal lesions and of 0.88
for SIJ lesions. The corresponding kappa values for the MRI modality were 0.64 and 0.93, respectively. More spinal
lesions were detected by MRI in comparison to PET/CT (68 vs. 38), whereas a similar number of SIJ quadrants
scored positive in both modalities (19 vs. 17). Analysis of agreement of lesion detection between both imaging
modalities yielded a kappa value of only 0.25 for spinal lesions and of 0.64 for SIJ lesions.
Conclusion: Increased 18 F-fluoride uptake in PET/CT is only modestly associated with bone marrow edema on
MRI in the spine and SIJ of patients with AS, suggesting different aspects of bone involvement in AS.
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Background
Ankylosing spondylitis (AS) is the main subtype of a
group of chronic inflammatory rheumatic diseases, called
the spondyloarthritides (SpA), which mainly affect the
axial skeleton as well as the peripheral joints and entheses
[1-3]. The main clinical manifestations, inflammatory back
pain and stiffness, are caused by inflammatory changes in
the sacroiliac joints (SIJ) and spinal structures (sacroiliitis,
spondylitis, spondylodiscitis, spondyloarthritis, and enthe-
sitis). The clinical symptoms are paralleled over time by
some osteodestructive and typical osteoproliferative
changes of SIJ and spine (erosions, syndesmophytes, and
ankylosis) best assessed by conventional radiographs [4].
MRI is able to detect acute inflammation of the SIJ and
the spine before structural changes develop and has be-
come a pivotal imaging tool for early diagnosis of axial
SpA (recently included as a major criterion in the ASAS
classification criteria) [5,6]. It has also allowed insights
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into the development of new bone from prior inflamma-
tory lesions. The current paradigm involves resolution of
an inflammatory lesion and its replacement by fat tissue
followed by cartilage metaplasia and osteoproliferation
through endochondral ossification [7,8]. This is exempli-
fied by the observation that syndesmophytes seem to pre-
ferentially develop at fatty degenerated vertebral corners
after resolution of inflammation [9,10]. However, syndes-
mophytes may also develop at sites without inflammation
on baseline and follow up MRI, potentially through nonin-
flammatory pathways [11,12].
High bone turnover assessed by nuclear medicine
methods may detect osteoproliferative processes regard-
less of the inflammatory or noninflammatory origin [13].
While exact localization of regions of radionuclide
uptake is difficult with conventional scintigraphy,
18F-fluoride PET/CT (F PET/CT) has a much better
spatial resolution and sensitivity [14,15]. In the present
pilot study, we systematically assessed regions of high
bone turnover as detected by F PET/CT within the spine
and the SIJ. We compared the distribution of the lesions
with the inflammation detected as bone marrow edema
on short tau inversion recovery (STIR) sequences by
whole-body MRI in the same patients.
Methods
Patients
Study population
Ten patients with active AS were prospectively
recruited in the Department of Rheumatology at
the University Hospital Zurich from a national
population-based prospective observational registry
of axial spondyloarthritis patients (Swiss Clinical
Quality Management (SCQM) in axial spondyloar-
thritis) and examined with both whole-body MRI
and 18 F-fluoride PET/CT. We received approval
from our Institutional Review Board (IRB) as well as
a written informed consent of each patient.
Inclusion criteria
Patients were included if they fulfilled the modified NY
criteria for AS and had a Bath Ankylosing Spondylitis
Disease Activity Index (BASDAI) of at least 4.
Exclusion criteria
Exclusion criteria were ongoing or previous therapy
(within the preceding 6 months) with tumor necrosis
factor alpha inhibitors, pregnancy, contraindications for
MRI imaging including cardiac pacemakers and neuro-
stimulators, prior spine surgery/metal implants, as well
as a time interval between F PET/CT and MRI of more
than 6 weeks.
Imaging protocol
Fluoride PET/CT scanning
All patients were examined in supine position on a com-
bined PET/CT system (Discovery RX or Discovery STE,
GE Healthcare, Milwaukee, WI, USA). These in-line sys-
tems contain a PET scanner and a multi-slice helical CT
scanner (16 or 64 slices) permitting the acquisition of
co-registered CT and PET images in the same session.
Scanning was started 30 to 45 min after the i.v. injection
of a median dose of 152 MBq (range 107 to 200 MBq)
of 18 F-fluoride. Directly after the low-dose CT acquisi-
tion (FOV 50 cm, 30 to 80 auto mA, 140 kV, slice-
thickness 3.75 mm, 0.5-s rotation time, standard recon-
struction type), 3D-PET emission data were acquired for
1.5 and 2 min/cradle position, respectively. The CT data
were used for attenuation correction as well as for the
determination of anatomic distribution of increased
radionuclide uptake, and images were reconstructed
using a fully 3D iterative algorithm (VUE Point HD).
Postprocessing of the acquired images was performed
with a dedicated software (Volume Viewer PET/CT, AW
4.4 workstation, GE Healthcare) providing multiplanar
reformatted images of PET alone, CT alone, and fused
PET/CT.
MRI protocol
Whole-body MR imaging was performed in all patients
using coronal and sagittal T1-weighted and STIR
sequences of the entire spine and sacrum, anterior chest
wall and shoulder, and pelvis. MR imaging was per-
formed on a 1.5-T magnet (Siemens Medical Solutions,
Erlangen, Germany), equipped with 18 independent
radiofrequency channels. A body matrix coil was used.
Coronal T1-weighted spin-echo (repetition time (TR),
573 ms; echo time (TE), 12 ms; PAT Factor 2; PAT mode
GRAPPA (generalized autocalibrating partially parallel
acquisition)) and coronal turbo STIR (TR, 9,860 ms; TE,
99 ms; TI, 130 ms; Turbo Factor 21, PAT Factor 2; PAT
mode GRAPPA) sequences were acquired using two im-
aging steps with a FOV of 450 mm×450 mm and an im-
aging matrix of 348 × 267 pixels/step, 5-mm slice
thickness, interslice gap 1 mm, 32 sections resulting in a
FOV of 785 × 450 mm. Sagittal T1-weighted spin-echo
(TR, 403 ms; TE, 11 ms; PAT Factor 2; PAT mode
GRAPPA) and sagittal turbo STIR (TR, 6,270 ms; TE,
93 ms; TI, 130 ms; Turbo Factor 21, PAT Factor 2, PAT
mode GRAPPA) sequences were acquired using two im-
aging steps with a FOV of 450 mm×450 mm and an im-
aging matrix of 448 × 268 pixels/step, 3-mm slice
thickness, interslice gap 0.3 mm, 20 sections resulting in
a FOV of 792 × 450 mm. Additional scans from the SI
joint centers included coronal T1-weighted turbo spin-
echo and STIR sequences angled parallel to the SI joint,
and a transverse STIR sequence perpendicular to the
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coronal sequences. The scan parameters for the two cor-
onal sequences were 19 slices, 4-mm slice thickness,
0.4-mm interslice gap, and field of view of 280 mm. For the
coronal T1-weighted sequence, TR was 423 to 450 msec,
TE was 12 to 13 msec, echo train length (ETL) was 3, and
matrix was 512×256 pixels. For the coronal STIR se-
quence, the values were TR 3,700 to 4,930 msec, inversion
time 145 to 150 msec, TE 50 to 69 msec, ETL 7 to 9, and
matrix 256 to 384×256 pixels. For the transverse sequence,
the values were 19 slices, 4.5-mm slice thickness, 0.6-mm
interslice gap, field of view of 280 mm, TR was 4,930 msec,
inversion time was 150 msec, TE was 69 msec, ETL was 9,
and matrix was 256×256 pixels.
Analysis of MRI
Scoring of MR images was done by two readers (CWAP
and VZ; staff radiologists experienced in musculoskeletal
MRI) not involved in patient recruitment and blinded to
clinical parameters and fluoride PET/CT. Increased bone
marrow signal, denoting inflammation in the SIJ, vertebral
bodies, and posterior spine elements was assessed on
STIR sequences. Positive T2 signal for inflammation was
defined as a signal that is greater than the signal from the
center of an adjacent normal vertebral body or bone.
Analysis of 18 F-fluoride PET/CT
Two nuclear physicians (DRF and KDMS) not involved
in patient recruitment and blinded to clinical para-
meters, and MRI analyzed PET/CT images visually.
Increased 18 F-fluoride activity, as a surrogate marker of
inflammation in the SIJ, vertebral bodies, and posterior
spine elements, was assessed on PET/CT. Increased ac-
tivity was defined as an activity that is greater than the
activity in the center of an adjacent normal vertebral
body or bone.
Reading
Reading of MRI or PET/CT was first done separately to
evaluate interobserver agreement. Images were then read in
consensus. Increased radionuclide uptake on PET/CT was
assessed in sagittal, axial, and coronal planes. Bone marrow
edema on MRI was assessed in coronal and sagittal planes
for the spine and in coronal and axial planes for the SIJ.
Spinal lesions
Spine
The following specific lesions were recorded in a dichot-
omous manner (present/absent): vertebral corner inflam-
matory lesions (CIL; anterior (a) and posterior (p), upper
(u) or lower (l)), vertebral lateral inflammatory lesions
(LIL; right (ri) or left (le); upper (u) or lower (l)), verte-
bral non-corner inflammatory lesions (NIL), and two
components of the posterior structures: first the poster-
ior elements (posterior element inflammatory lesion
(PIL)) including transverse and spinous process, costo-
vertebral and costotransversal joints, and secondly the
facet joints (facet joint inflammatory lesion (FIL)). In the
cervical spine, as it is not possible to apply these defini-
tions because the individual components of the posterior
elements cannot be reliably separated, the presence of
abnormal T2 signal or PET activity in any posterior
element of the cervical spine was recorded dichotom-
ously, treating the posterior arch of the vertebra as a sin-
gle structure (cervical posterior inflammatory lesion
(CPIL)) [16,17].
The following attribution rules were applied to avoid
double counting and to assist with agreement analysis:
1. Bilateral lesions for FIL and more than one lesion
for NIL, PIL, and CPIL were counted as a single
positive for that structure.
2. Lesions in facet joints were assigned to the vertebral
levels of the inferior facet of the joint.
Table 1 Patient characteristics
Patient Gender Age BASDAI BASFI CRP Time between PET/CT and MRI (days)
1 m 56 4.3 4.2 2 9
2 w 38 4.7 4.8 17 29
3 m 47 4.1 4.3 11 2
4 w 55 7.4 6.8 1 16
5 w 30 5.1 4.4 6 3
6 m 43 7.1 7.5 2 7
7 m 58 4.7 4.4 41 3
8 w 44 5.4 6.0 1 21
9 m 44 4.1 4.2 3 38
10 m 32 6.8 6.4 24 18
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C-reactive protein (mg/l); m, men; w, women.
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3. CIL were assessed on sagittal images depicting the
spinal channel; LIL were assessed on sagittal images
strictly lateral to the spinal channel.
SIJ lesions
Each SI joint was scored in four quadrants (superior and
inferior iliac and sacral quadrants) regardless of the extent
of the lesion (orientation strictly coronal to the body axis).
As a last step, all lesions that had revealed increased
tracer uptake on PET/CT and no edema on MRI in con-
sensus reading were again analyzed by one reader (VZ)
with regard to the presence of fatty alterations on T1-
weighted MRI sequences at these locations.
Statistics
Agreement of detection of lesions between the readers
and modalities was analyzed using kappa values. At first,
kappa values were calculated regarding the agreement
of detection between readers in PET/CT (DRF and
KDMS) and in MRI (CWAP and VZ) separately for
spinal and SIJ lesions. As a next step, consensus reading
of PET/CT and MRI was analyzed calculating kappa
values for the agreement of lesion detection between
both imaging modalities again separately for spinal and
SIJ lesions. Because of the assessment of several locali-
zations within the same patient and the small number
of patients, no confidence limits are presented.
Table 2 Distribution of spinal lesions on PET/CT and MRI
u-aCIL u-pCIL l-aCIL l-pCIL u-LIL ri u-LIL le I-LIL ri I-LIL le NIL CPIL PIL FIL
Patient 1
PET/CT C6 Th10
MRI L3 L1, L2 S1 S1 L5 L5
Patient 2
PET/CT
MRI
Patient 3
PET/CT
MRI
Patient 4
PET/CT Th11 Th6, L3, S1
MRI
Patient 5
PET/CT L2
MRI Th4
Patient 6
PET/CT Th6
MRI
Patient 7
PET/CT Th2, Th3,
Th 5-10
Th7 Th8, Th10 Th1-12 L1
MRI Th1, Th3, Th8,
Th10-12
Th5 Th2, Th8-12, L2 Th4 L1-3 Th3, Th7 L2, L3 Th3-5, L2 Th9-11 Th3-10, L1, L4 Th3-7,
Th12
Patient 8
PET/CT C3 C5 Th5
MRI L5
Patient 9
PET/CT C5
MRI C7, Th1, L4, L5 C6, C7 C6 C5, C6 C6, Th1 C5
Patient 10
PET/CT Th10 Th10
MRI Th5 Th4
a, anterior; CIL, corner inflammatory lesion; CPIL, cervical posterior inflammatory lesion; FIL, facet joint inflammatory lesion; l, lower; le, left; LIL, lateral inflammatory
lesion; NIL, non-corner inflammatory lesion; p, posterior; PIL, posterior element inflammatory lesion; u, upper; ri, right.
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Statistical analyses were performed using IBM SPSS Sta-
tistics (version 19, SPSS Inc., Chicago, IL, USA).
Results
Patient characteristics
Ten patients (6 men, 4 women) with AS as classified by
the modified New York criteria and a median age of
44 years (range 30 to 58 years) participated in this study.
They had a median BASDAI of 4.9 (range 4.1 to 7.4) and
a median Bath Ankylosing Spondylitis Functional Index
(BASFI) of 4.6 (range 4.2 to 7.5). The median C-reactive
protein level was 4.5 mg/l (range 1 to 41). Time interval
between both imaging modalities ranged from 2 to
38 days (Table 1).
Interobserver agreement for F PET/CT and MRI of spinal
lesions
Reader agreement was assessed by kappa statistics for
each imaging modality. The interobserver agreement for
F PET/CT was 0.68 for spinal lesions and 0.88 for SIJ
lesions. Interobserver agreement for MRI ranged from
0.64 for spinal lesions to 0.93 for the SIJ lesions.
Anatomic distribution of lesions detected by F PET/CT
and MRI
All patients had increased radionuclide uptake in at least
one area on F PET/CT (spine and SIJ in four patients,
only in the spine in four patients, and only in the SIJ in
two patients). A total of 38 areas with increased uptake
in the spine were detected by F PET/CT: 17 vertebral
body lesions (10 aCIL, 3 LIL, 4 NIL) and 21 lesions
within the posterior spine structures, with the thoracic
spine most frequently affected (30/38 = 79% of lesions).
With regard to SIJ involvement, radionuclide uptake was
recorded in 17 SIJ quadrants.
Nine out of ten patients had inflammatory lesions on
MRI (four patients had lesions in both spine and SIJ,
two patients had lesions only in the spine, and three
patients had only SIJ lesions). MRI detected 68 inflam-
matory spinal lesions (41/68 = 60% of them in the thor-
acic spine), 52 vertebral body lesions (21 aCIL, 9 pCIL,
19 LIL, 3 NIL), and 16 posterior lesions. Nineteen SIJ
quadrants showed signs of bone marrow edema (Tables 2
and 3).
Association between radionuclide uptake in F PET/CT and
inflammation on MRI for the spine
Only 14 spine lesions were recorded concordantly by
both methods (MRI and F PET/CT): 6 vertebral body
lesions and 8 lesions within the posterior spine struc-
tures. Twenty-four spinal lesions detected by F PET/CT
had no inflammatory character on MRI, while only a mi-
nority of them corresponded to fatty changes on T1-
weighted MRI sequences (data not shown). A total of 54
acute inflammatory lesions on MRI showed no increased
activity on F PET/CT imaging (Table 4). An example is
shown in Figure 1. Analysis of consensus reading of
PET/CT and MRI with regard to agreement of spinal le-
sion detection between both imaging modalities yielded
a kappa value of only 0.25. Some lesions detected may
be the consequence of concurrent degenerative spine
disease as exemplified in Figure 2.
Association between radionuclide uptake in F PET/CT and
inflammation on MRI for SIJ quadrants
A better agreement between the two imaging methods
was found for inflammation in SIJ quadrants (kappa
Table 3 Distribution of lesions in sacroiliac joint
quadrants on PET/CT and MRI
Positive sacroiliacal joint quadrants
Patient 1
PET/CT
MRI
Patient 2
PET/CT R-Inf-Iliac, R-Inf-Sacr, L-Inf-Sacr
MRI R-Inf-Iliac, R-Inf-Sacr, L-Inf-Sacr
Patient 3
PET/CT R-Inf-Iliac, R-Inf-Sacr, L-Inf-Iliac, L-Inf-Sacr
MRI R-Inf-Sacr, L-Inf-Sacr
Patient 4
PET/CT
MRI L-Inf-Iliac
Patient 5
PET/CT R-Inf-Iliac, R-Inf-Sacr, L-Inf-Iliac, L-Inf-Sacr
MRI R-Inf-Iliac, R-Sup-Sacr, R-Inf-Sacr, L-Inf-Iliac,
L-Sup-Sacr, L-Inf-Sacr
Patient 6
PET/CT
MRI
Patient 7
PET/CT R-Sup-Iliac, R-Inf-Iliac
MRI
Patient 8
PET/CT R-Inf-Iliac, L-Inf-Iliac
MRI R-Inf-Iliac,R-Inf-Sacr,L-Inf-Iliac,L-Inf-Sacr
Patient 9
PET/CT
MRI L-Inf-Sacr
Patient 10
PET/CT L-Inf-Iliac,L-Inf-Sacr
MRI L-Inf-Iliac,L-Inf-Sacr
Inf, inferior; L, left; R, right; Sacr, sacral; Sup, superior.
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value 0.64): 13/80 SIJ quadrants had lesions recorded by
both methods, while 4 lesions were detected only by F
PET/CT, and 6 only by MRI (Table 4, Figure 3). How-
ever, the evaluated SIJ quadrants were quite large, and
retrospective comparison of the changes of SIJ quadrants
in both modalities showed that in the SIJ edema and
increased 18 F-fluoride uptake, although situated in the
same quadrants, did not all show an exact overlap
(Figure 4).
Discussion
The results of the present descriptive pilot study suggest
that the radiotracer uptake detected by F PET/CT in the
spine and SIJ of patients with AS is only marginally asso-
ciated with the concomitant MRI evidence of inflamma-
tion. The relationship between active inflammatory MRI
lesions at vertebral corners and the development of syn-
desmophytes as assessed on conventional radiographs
has been analyzed in several recent studies [8-12,18,19].
Although clear longitudinal data are still lacking, these
studies point to a process that comprises resolution of
inflammation, activation of repair mechanisms involving
fatty transformation of the lesion followed by new bone
formation. However, new syndesmophytes may develop
at sites without inflammation or fat infiltration on base-
line MRI [11,12]. These findings suggest the presence of
non-inflammatory pathways, although the presence of
underlying inflammation not detectable by MRI cannot
Table 4 Number of associated and non-associated positive lesions in PET/CT and/or MRI in consensus reading
PET/CT positive/MRI positive PET/CT negative/MRI positive PET/CT positive/MRI negative
Spinal lesions 14 54 24
SIJ lesions 13 6 4
Figure 1 Forty-four-year-old male patient (patient number 9). Patient with an u-aCIL L4, L5 on MRI (arrows) without corresponding increased
activity on F PET/CT (arrowheads). Sagittal STIR (a), fused PET/CT (b), CT (c), and PET (d) images.
Figure 2 Fifty-five-year-old female patient (patient number 4). Patient with fluid within the left facet joint S1 (arrow) on MRI and
corresponding increased activity on F PET/CT (arrowhead) indicating activated degenerative facet joint osteoarthritis. Left parasagittal STIR (a),
fused PET/CT (b), CT (c), and PET (d) images.
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be formally excluded. F PET/CT might be able to detect
the anabolic repair process leading to new bone forma-
tion regardless of the definite pathophysiological path-
way. It was therefore anticipated that 18 F-fluoride
uptake might also occur in active mineral deposition
associated with degenerative spine disease (as exempli-
fied in Figure 2), especially as patients with established,
longstanding AS were included in this study. Longitu-
dinal studies in patients with early axial SpA with only
minimal degenerative disease are warranted.
Figure 3 Thirty-two-year-old male patient (patient number10). Patient with positive findings in the inferior iliac and sacral quadrant of the
left iliosacral joint both on MRI (edema, arrows) and on F PET/CT (arrowheads). Axial STIR (a), fused PET/CT (b), CT (c), and PET (d) images.
Figure 4 Thirty-year-old female patient (patient number 5). Patient with positive findings in all four inferior iliosacral quadrants both on MRI
and F PET/CT without exact overlap. Axial STIR images (left) and fused PET/CT images (right).
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Also, as this is a rather small study group (n=10), fur-
ther studies have to be performed with a larger patient
population to verify our findings. As a next step, repeated
imaging and clinical observations over a long time period
would be necessary in order to appreciate the predictive
value and the clinical relevance of the (discrepant) findings
in both imaging modalities described, including their im-
pact on patient management.
In this study, we focused on the functional part of F
PET/CT. The low-dose CT part was used for attenu-
ation correction and for lesion localization. Evaluation of
the CT findings (especially if adding a dedicated thin-
slice CT) and their potential contribution to the diag-
nostic process could be of additional value.
In contrast to spinal disease, a comparable frequency
of increased 18 F-fluoride uptake on PET/CT and bone
marrow edema on whole-body MRI was found at the
level of SIJ quadrants, with a substantial agreement in
their distribution between the two methods. Yet, within
the same quadrant, increased radionuclide uptake and
bone marrow edema did not all show an exact overlap.
Conclusion
F PET/CT may provide additional information to MRI
evaluation in patients with AS, both in spinal and in SIJ
involvement. Whether radionuclide uptake detected with
this method or with hybrid 18 F-fluoride PET/MRI tech-
nology performed on the same day might be able to bet-
ter predict syndesmophyte formation, a hallmark of the
disease, should be investigated in larger studies.
Endnotes
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Board (IRB), and Swissmedic was duly notified. Amend-
ments to the protocol for this study, suppressing bone
scans, and extending the number of subjects were also
approved by the IRB; however, it was omitted to notify
Swissmedic about these amendments.
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